FDA Inspection 1227272 — Amoli Organics (A Division of Umedica Laboratories Pvt. Ltd.)
The FDA completed an inspection of Amoli Organics (A Division of Umedica Laboratories Pvt. Ltd.) on January 12, 2024 in Padra. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- January 12, 2024
- Fiscal Year
- 2024
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Padra (India)